Overview
Also known as:
FDA & Trial Timeline
10 eventsFondazione Italiana Linfomi - ETS
Sun Yat-sen University — PHASE2
University of Maryland, Baltimore — PHASE1
St. Petersburg State Pavlov Medical University — PHASE1, PHASE2
Allogene Therapeutics — PHASE2
Sun Yat-sen University — PHASE2
Memorial Sloan Kettering Cancer Center — PHASE1
Acepodia Biotech, Inc. — PHASE1
IRCCS San Raffaele
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableBreyanzi
adult patients with large B-cell lymphoma (LBCL), including primary mediastinal large B-cell lymphoma, who have refractory disease to first-line chemoimmunotherapy or relapse within 12 months of first…
adult patients with large B-cell lymphoma (LBCL), including primary mediastinal large B-cell lymphoma, who have refractory disease to first-line chemoimmunotherapy or relapse within 12 months of first-line chemoimmunotherapy; or refractory disease to first-line chemoimmunotherapy or relapse after first-line chemoimmunotherapy and are not eligible for hematopoietic stem cell transplantation (HSCT) due to comorbidities or age; or relapsed or refractory disease after 2 or more lines of systemic therapy
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Primary mediastinal large B-cell lymphoma.
Community
No community posts yet. Be the first to share your experience with Primary mediastinal large B-cell lymphoma.
Start the conversation →Latest news about Primary mediastinal large B-cell lymphoma
Disease timeline:
New recruiting trial: Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: Italian Observational Study on CAR-T Therapy for Lymphoma
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: Bio-CAR-T BS Study
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
New recruiting trial: PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
A new clinical trial is recruiting patients for Primary mediastinal large B-cell lymphoma
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary mediastinal large B-cell lymphoma
Are there clinical trials for Primary mediastinal large B-cell lymphoma?
Yes — 10 recruiting clinical trials are currently listed for Primary mediastinal large B-cell lymphoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Primary mediastinal large B-cell lymphoma?
25 specialists and care centers treating Primary mediastinal large B-cell lymphoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.